Prednisone, an agonist of the glucocorticoid receptor (GR; gene NR3C1), is prescribed as a potent anti-inflammatory drug and considered standard of care for DMD (Griggs et al, 2013, 2016; Bello et al, 2015a). This evidence concerns the gene NR3C1 and Duchenne muscular dystrophy.